39
Participants
Start Date
August 25, 2022
Primary Completion Date
July 19, 2023
Study Completion Date
July 19, 2023
TQB3823 tablets
TQB3823 tablet is an inhibitor of poly ADP-ribose polymerase (PARP).
Abiraterone acetate tablets
Abiraterone acetate tablet is an inhibitor of cytochrome P450 17（CYP17）
prednisone acetate tablets
Prednisone acetate tablet is a kind of glucocorticoids
The First Hospital of Peking University, Beijing
Shengjing Hospital Affiliated to China Medical University, Shenyang
Affiliated Cancer Hospital of Harbin Medical University, Harbin
Huadong Hospital Affiliated to Fudan University, Shanghai
Jiangsu Province Hospital, Nanjing
Shandong Cancer Hospital, Jinan
Cancer Hospital of Tianjin Medical University, Tianjin
The First Affiliated Hospital of Wenzhou Medical Univerity, Wenzhou
The Southwest Hospitai of Amu, Chongqing
Chongqing Cancer Hospital, Chongqing
Hunan Cancer Hospital, Changsha
Qingyuan People's Hospital, Qingyuan
Sun Yat-Sun University Cancer Prevertion and Treatment Center, Guangzhou
The First Affiliated Hospital of Guangxi Medical University, Nanning
West China Hospital，Sichuan University, Chengdu
Sichuan Provincial People's Hospital, Chengdu
Mianyang Central Hospital, Mianyang
Zigong Fourth People's Hospital, Zigong
The Affiliated Hospital of Southwest Medical University, Luzhou
The First Affiliated Hospital of Kunming Medical University, Kunming
Second Affiliated Hospital of Kunming Medical University, Kunming
The First Affiliated Hospital of The Chinese People's Liberation Army Air Force Military Medical University, Xi’an
The Second Hospital of Harbin Medical University, Lanzhou
Lead Sponsor
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
INDUSTRY